Longboard pharmaceuticals to present at two upcoming investor conferences in february

La jolla, calif.--(business wire)---- $lbph #epilepsy--longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that members of its senior leadership team will present at two upcoming investor conferences in february. conference details: event: guggenheim healthcare talks 6th annual biotechnology conference details: presenting in a fireside chat format on wednesday, february 7, 2024, a.
LBPH Ratings Summary
LBPH Quant Ranking